SCHEMBL20061790

SCHEMBL20061790

c1ccc2cc3c(cc2c1)C1c2ccncc2C3c2nccnc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.35
MAPT P10636 3/20 0.35
CYP17A1 P05093 2/20 0.34
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
NPC1 O15118 3/20 0.34
ALDH1A1 P00352 2/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
PLAU P00749 1/20 0.33
PDGFRB P09619 1/20 0.33
PDGFRA P16234 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
RAD52 P43351 1/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20061803 0.88 HSP90AA1 (0.37) ALDH1A1HPGDKDM4EPOLBHTT
SCHEMBL20061801 0.86 CYP17A1 (0.38) PDPK1MAPTCYP17A1CYP19A1CYP11B1
SCHEMBL20061788 0.86 PDPK1 (0.38) PDPK1MAPTNPC1ALDH1A1HPGD
SCHEMBL20061791 0.84 MAPK9 (0.37) PDPK1MAPTCYP17A1CYP19A1CYP11B1
SCHEMBL20061818 0.84 MAPK9 (0.37) PDPK1MAPTCYP17A1CYP19A1CYP11B1
SCHEMBL20061813 0.84 CYP2A6 (0.31) CLK1CYP2A6CSNK1DCSNK1EDYRK1A
SCHEMBL20061815 0.84 KDM4E (0.34) ALDH1A1KDM4EHTT
SCHEMBL20061799 0.76 ALDH1A1 (0.36) PDPK1MAPTCYP17A1CYP19A1CYP11B1
SCHEMBL20061805 0.74 ALDH1A1 (0.38) PDPK1MAPTCYP17A1CYP19A1CYP11B1
SCHEMBL20061785 0.73 L3MBTL1 (0.38) MAPTNPC1ALDH1A1PKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180108848-A1 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108848-A1 Organic electroluminescent materials and devices OSBP, OSBP2, OCIAD2 PDPK1 1700/4885MAPT 1768/4885CYP17A1 3110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.